- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03058328
The White Blood Cell Reactivity Following Surgical Trauma and Associated Regulatory Mechanisms.
Post-surgery Systemic Inflammation and Neuro-immune Interactions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Surgical trauma causes release of damage-associated molecular patterns (DAMPs) and other alarmines (e.g. HMGB-1) targeting receptors on local cells of the innate immune system, such as macrophages. This cellular response to trauma is followed by a rapid release of an array of inflammatory mediators (e.g. TNFα, IL-1B, IL-6, IL-8, IL-10) being dependent on intracellular activation of nuclear factor NF-kB. Until recently it was believed that the brain is protected from this cascade of inflammatory mediators primarily due to an intact blood-brain-barrier (BBB). However, there is now a growing body of evidence that long term impairment of brain functions is associated with trauma-induced activation of the brain innate immune system with subsequent impairment of higher cognitive processes and risk for later permanent dementia. Yet, the link between systemic inflammation and cognitive impairment is not fully understood.
Recent studies have mapped periphery-to-brain-signaling after surgical trauma and the impact of major surgical trauma on the human brain by serial PET-imaging. In series of surgical patients, profound and biphasic changes in brain immune activity after surgery has been demonstrated after major abdominal surgery with signs of early depression followed by an increased immune activity at 3 months postoperatively. These biphasic changes in brain immunity seem to be aligned with simultaneous changes in whole blood immune reactivity to LPS suggesting a close link between brain and peripheral immune systems in regulation of acute inflammation and immune responses. Preclinical work in surgical animal models indicates disruption of the BBB with migration of peripheral macrophages into the brain as a pathway of potential importance. Evidence from an orthopedic surgery model in mice of trauma-induced altered hippocampal neuro-immune activity further raises the question whether peripheral markers of neurodegeneration (S100b, neurofilament light NFL, ptau, beta-amyloid) are associated with POCD.
The immune-regulatory role of the brain via the cholinergic anti-inflammatory reflex pathway (mediated by the vagal nerve) has been identified as potential target for immune-modulatory treatment strategies in systemic inflammation. We have moreover demonstrated a distinct release of human carotid body inflammatory mediators at hypoxia and gene expression related to inflammatory mediators, suggesting a potential role of the human carotid body in periphery-to-brain immune-signaling. Modulation of a vagal nerve-derived inflammatory reflex pathway by electrical stimulation has recently been successfully applied in treatment of chronic inflammation among patients with rheumatoid arthritis.
The hypothesis is that vagal nerve activity modulates systemic inflammation in patients after major surgery and that this modulation is associated with cognitive performance in the postoperative period.
With a more comprehensive understanding of immune-to-brain signaling after surgical trauma and how this biphasic inflammatory response pattern is regulated by cellular and neuronal components, the impact of immune modulation on key processes behind surgery-induced brain dysfunction can be explored, and possible neural and humoral targets for relevant anti-inflammatory treatments established.
In abdominal surgery patients we will map inflammatory periphery-to-brain communication by description of the temporal association between brain regulation of peripheral immunity (i.e., temporal changes in vagal nerve activity as measured by serial measurements of heart rate variability), repeated blood reactivity to LPS by serial ex vivo LPS challenge and simultaneous plasma/serum-borne CNS inflammatory and brain injury biomarkers to explore the impact of changes in systemic and brain immune function after surgery on long-term cognitive performance.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden
- Karolinska Universitetssjukhuset Solna
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
INCLUSION CRITERIA
- Diagnosed prostate disease who are scheduled for elective robot assisted prostate surgery (RALP) and who are otherwise healthy
- A body mass index (BMI) below 33
- Mini-mental state examination (MMSE) scoring >23
EXCLUSION CRITERIA
Exclusion criteria are patients with:
- Neurodegenerative disease
- Significant psychiatric illness
- Previous stroke
- Pacemaker, myocardial infarction or cardiac arrhythmias,
- Known obstructive coronary artery disease, left ventricular hypertrophy or New York Heart Association (NYHA) class 2-4 heart failure
- Chronic pain or inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, SLE, psoriasis
- Steroidal therapy
- Statin medication
- Medication with ß-blockers, anti-cholinergic medication
- Poorly controlled diabetes mellitus or any other condition known to cause autonomic dysfunction
- Abuse of alcohol or drugs
- Previous splenectomy
- Presumed uncooperativeness or legal incapacity.
The patient should not have:
- undergone surgery the last 6 months
- been treated for cancer the last 12 months
- been treated for infectious disease the previous month.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in subsets of Monocytes after surgical trauma
Time Frame: Up to 6 months after surgery
|
Changes in subsets of Monocytes after surgical trauma
|
Up to 6 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
T-cell numbers after surgical trauma.
Time Frame: Up to 6 months after surgery
|
T-cell numbers after surgical trauma.
|
Up to 6 months after surgery
|
B-cell numbers after surgical trauma.
Time Frame: Up to 6 months after surgery
|
B-cell numbers after surgical trauma.
|
Up to 6 months after surgery
|
T-cell functionality changes after surgical trauma.
Time Frame: Up to 6 months after surgery
|
T-cell functionality changes after surgical trauma.
|
Up to 6 months after surgery
|
B-cell functionality changes after surgical trauma.
Time Frame: Up to 6 months after surgery
|
B-cell functionality changes after surgical trauma.
|
Up to 6 months after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Genetic response to surgical trauma
Time Frame: Up to 6 months after surgery
|
Genetic response to surgical trauma, i.e. white blood cell RNA sequencing
|
Up to 6 months after surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lars I Eriksson, Karolinska University Hospital and Karolinska Institutet
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- POSINI2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuroinflammation
-
PfizerCompleted
-
Mayo ClinicEnrolling by invitation
-
VA Office of Research and DevelopmentOregon Health and Science University; Portland VA Medical CenterRecruitingMethamphetamine-dependenceUnited States
-
Chang Gung Memorial HospitalRecruitingThe Association of Postoperative Cognitive Dysfunction With Glymphatic Function and Neuroinflammation | The Association of Postoperative Cognitive Dysfunction With CSF Metabolomic ChangeTaiwan
-
University of Alabama at BirminghamCompleted
-
Columbia UniversityNational Institute on Aging (NIA)Active, not recruitingInflammation | Memory LossUnited States
-
New York State Psychiatric InstituteRecruiting
-
University of Alabama at BirminghamActive, not recruitingMyocardial InfarctionUnited States
-
University of PennsylvaniaTerminatedMild Cognitive ImpairmentUnited States
-
University of Alabama at BirminghamRecruiting
Clinical Trials on Cognitive testing, testing of heart rate variability and blood samples
-
Vladikavkaz Scientific Center of the Russian Academy...RecruitingConditionally Healthy Persons | Persons With a High Body Mass IndexRussian Federation
-
Rutgers, The State University of New JerseyNepalese Psychological Association; New Jersey Psychological AssociationCompletedSmoking Cessation | Stress | Stress, Emotional | Smoking, Cigarette | Stress ReactionUnited States
-
Hippocration General HospitalKAT General Hospital; Sismanoglio General Hospital; Thriasio General Hospital; Elpis... and other collaboratorsRecruitingMyocardial Infarction With Nonobstructive Coronary ArteriesGreece
-
University of Medicine and Dentistry of New JerseyPfizerCompletedBlood Pressure | Heart RateUnited States
-
University Hospital, BrestTerminated
-
Cedars-Sinai Medical CenterActive, not recruitingMicrovascular Coronary DysfunctionUnited States
-
University of AlbertaCanadian VIGOUR CentreCompletedCoronavirus Infection | Covid19 | SARS-CoV InfectionCanada
-
Ain Shams UniversityUnknownICU Acquired Weakness | Thyroid AbnormalitiesEgypt
-
Washington University School of MedicineCompletedAlzheimer Disease | Alzheimer DementiaUnited States
-
University Health Network, TorontoThe Physicians' Services Incorporated FoundationCompleted